Peripheral Neuropathy: A Practical Approach to Diagnosis and Symptom Management

Mayo Clinic Proceedings

Volumn 90, Issue 7, 2015, Pages 940-951

  Watson, James C ^a   Dyck, P James B ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIFFERENTIAL DIAGNOSIS; DISEASE MANAGEMENT; HUMAN; PERIPHERAL NERVOUS SYSTEM DISEASES; PRACTICE GUIDELINE;

DIAGNOSIS, DIFFERENTIAL; DISEASE MANAGEMENT; HUMANS; PERIPHERAL NERVOUS SYSTEM DISEASES; PRACTICE GUIDELINES AS TOPIC;

EID: 84934342670     PISSN: 00256196     EISSN: 19425546     Source Type: Journal    
DOI: 10.1016/j.mayocp.2015.05.004     Document Type: Review

References (62)

1. J.L. St Sauver, D.O. Warner, B.P. Yawn, and et al. Why patients visit their doctors: assessing the most prevalent conditions in a defined American population Mayo Clin Proc 88 1 2013 56 67
2. C.J. Hsiao, K. Donald, D.K. Cherry, P.C. Beatty, and E.A. Rechtsteiner National Ambulatory Medical Care Survey: 2007 summary Natl Health Stat Report 27 2010 1 32
3. Centers for Disease Control and Prevention. National Ambulatory Medical Care Survey factsheet: neurology. Centers for Disease Control and Prevention website. http://www.cdc.gov/nchs/data/ahcd/NAMCS-2010-factsheet-neurology.pdf. Accessed May 13, 2015.
4. C.N. Martyn, and R.A. Hughes Epidemiology of peripheral neuropathy J Neurol Neurosurg Psychiatry 62 4 1997 310 318
5. Italian General Practitioner Study Group (IGPSG) Chronic symmetric symptomatic polyneuropathy in the elderly: a field screening investigation in two Italian regions, I: Prevalence and general characteristics of the sample Neurology 45 10 1995 1832 1836
6. J. Partanen, L. Niskanen, J. Lehtinen, E. Mervaala, O. Siitonen, and M. Uusitupa Natural history of peripheral neuropathy in patients with non-insulin-dependent diabetes mellitus N Engl J Med 333 2 1995 89 94
7. A.J.M. Boulton Management of diabetic peripheral neuropathy Clin Diabetes 23 1 2005 9 15
8. P.J. Dyck, K.M. Kratz, J.L. Karnes, and et al. The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study [published correction appears in Neurology. 1993;43(11):2345] Neurology 43 4 1993 817 824
9. E.W. Gregg, P. Sorlie, R. Paulose-Ram, and et al. Prevalence of lower-extremity disease in the US adult population ≥40 years of age with and without diabetes: 1999-2000 National Health and Nutrition Examination Survey Diabetes Care 27 7 2004 1591 1597
10. American Diabetes Association Standards of medical care in diabetes - 2014 Diabetes Care 37 suppl 1 2014 S14 S80
11. A.J. Boulton, D.G. Armstrong, S.F. Albert, and et al. Comprehensive foot examination and risk assessment: a report of the Task Force of the Foot Care Interest Group of the American Diabetes Association, with endorsement by the American Association of Clinical Endocrinologists Diabetes Care 31 8 2008 1679 1685
12. B.A. Perkins, D. Olaleye, B. Zinman, and V. Bril Simple screening tests for peripheral neuropathy in the diabetes clinic Diabetes Care 24 2 2001 250 256
13. D. Olaleye, B.A. Perkins, and V. Bril Evaluation of three screening tests and a risk assessment model for diagnosing peripheral neuropathy in the diabetes clinic Diabetes Res Clin Pract 54 2 2001 115 128
14. N. Kamei, K. Yamane, S. Nakanishi, and et al. Effectiveness of Semmes-Weinstein monofilament examination for diabetic peripheral neuropathy screening J Diabetes Complications 19 1 2005 47 53
15. M. Al-Geffari Comparison of different screening tests for diagnosis of diabetic peripheral neuropathy in primary health care setting Int J Health Sci (Qassim) 6 2 2012 127 134
16. D.G. Armstrong, L.A. Lavery, S.A. Vela, T.L. Quebedeaux, and J.G. Fleischli Choosing a practical screening instrument to identify patients at risk for diabetic foot ulceration Arch Intern Med 158 3 1998 289 292
17. A.J. Boulton, A.I. Vinik, J.C. Arezzo, and et al. Diabetic neuropathies: a statement by the American Diabetes Association Diabetes Care 28 4 2005 956 962
18. G. Odenheimer, H.H. Funkenstein, L. Beckett, and et al. Comparison of neurologic changes in 'successfully aging' persons vs the total aging population Arch Neurol 51 6 1994 573 580
19. J.D. England, G.S. Gronseth, G. Franklin, and et al. Practice Parameter: evaluation of distal symmetric polyneuropathy: role of laboratory and genetic testing (an evidence-based review); report of the American Academy of Neurology, American Association of Neuromuscular and Electrodiagnostic Medicine, and American Academy of Physical Medicine and Rehabilitation Neurology 72 2 2009 185 192
20. B. Callaghan, R. McCammon, K. Kerber, X. Xu, K.M. Langa, and E. Feldman Tests and expenditures in the initial evaluation of peripheral neuropathy Arch Intern Med 172 2 2012 127 132
21. M. Davies, S. Brophy, R. Williams, and A. Taylor The prevalence, severity, and impact of painful diabetic peripheral neuropathy in type 2 diabetes Diabetes Care 29 7 2006 1518 1522
22. C.E. Argoff, B.E. Cole, D.A. Fishbain, and G.A. Irving Diabetic peripheral neuropathic pain: clinical and quality-of-life issues Mayo Clin Proc 81 4, suppl 2006 S3 S11
23. K. Van Acker, D. Bouhassira, D. De Bacquer, and et al. Prevalence and impact on quality of life of peripheral neuropathy with or without neuropathic pain in type 1 and type 2 diabetic patients attending hospital outpatients clinics Diabetes Metab 35 3 2009 206 213
24. Diabetes Control and Complications Trial Research Group The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus N Engl J Med 329 14 1993 977 986
25. B. Fullerton, K. Jeitler, M. Seitz, K. Horvath, A. Berghold, and A. Siebenhofer Intensive glucose control versus conventional glucose control for type 1 diabetes mellitus Cochrane Database Syst Rev 2 2014 CD009122
26. B. Hemmingsen, S.S. Lund, C. Gluud, and et al. Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitus Cochrane Database Syst Rev 11 2013 CD008143
27. P.J. Dyck, J.E. Norell, and P.J. Dyck Microvasculitis and ischemia in diabetic lumbosacral radiculoplexus neuropathy Neurology 53 9 1999 2113 2121
28. J.R. Singleton, A.G. Smith, and M.B. Bromberg Increased prevalence of impaired glucose tolerance in patients with painful sensory neuropathy Diabetes Care 24 8 2001 1448 1453
29. J.R. Singleton, A.G. Smith, and M.B. Bromberg Painful sensory polyneuropathy associated with impaired glucose tolerance Muscle Nerve 24 9 2001 1225 1228
30. C.J. Sumner, S. Sheth, J.W. Griffin, D.R. Cornblath, and M. Polydefkis The spectrum of neuropathy in diabetes and impaired glucose tolerance Neurology 60 1 2003 108 111
31. W.Y. Fujimoto, D.L. Leonetti, J.L. Kinyoun, W.P. Shuman, W.C. Stolov, and P.W. Wahl Prevalence of complications among second-generation Japanese-American men with diabetes, impaired glucose tolerance, or normal glucose tolerance Diabetes 36 6 1987 730 739
32. P.J. Dyck, V.M. Clark, C.J. Overland, and et al. Impaired glycemia and diabetic polyneuropathy: the OC IG Survey Diabetes Care 35 3 2012 584 591
33. 12 deficiency N Engl J Med 368 2 2013 149 160
34. D.S. Saperstein, G.I. Wolfe, G.S. Gronseth, and et al. Challenges in the identification of cobalamin-deficiency polyneuropathy Arch Neurol 60 9 2003 1296 1301
35. A.G. Smith, and J.R. Singleton The diagnostic yield of a standardized approach to idiopathic sensory-predominant neuropathy Arch Intern Med 164 9 2004 1021 1025
36. J.J. Kelly Jr., R.A. Kyle, P.C. O'Brien, and P.J. Dyck Prevalence of monoclonal protein in peripheral neuropathy Neurology 31 11 1981 1480 1483
37. S.N. Kahn, and M. Bina Sensitivity of immunofixation electrophoresis for detecting IgM paraproteins in serum Clin Chem 34 8 1988 1633 1635
38. J.S. Katz, D.S. Saperstein, G. Gronseth, A.A. Amato, and R.J. Barohn Distal acquired demyelinating symmetric neuropathy Neurology 54 3 2000 615 620
39. D.S. Saperstein, J.S. Katz, A.A. Amato, and R.J. Barohn Clinical spectrum of chronic acquired demyelinating polyneuropathies Muscle Nerve 24 3 2001 311 324
40. A. Mygland, and P. Monstad Chronic acquired demyelinating symmetric polyneuropathy classified by pattern of weakness Arch Neurol 60 2 2003 260 264
41. M.L. Mauermann, E.J. Sorenson, A. Dispenzieri, and et al. Uniform demyelination and more severe axonal loss distinguish POEMS syndrome from CIDP J Neurol Neurosurg Psychiatry 83 5 2012 480 486
42. R.L. Chin, H.W. Sander, T.H. Brannagan, and et al. Celiac neuropathy Neurology 60 10 2003 1581 1585
43. A. McKeon, V.A. Lennon, S.J. Pittock, T.J. Kryzer, and J. Murray The neurologic significance of celiac disease biomarkers Neurology 83 20 2014 1789 1796
44. N. Kumar, J.B. Gross Jr., and J.E. Ahlskog Copper deficiency myelopathy produces a clinical picture like subacute combined degeneration Neurology 63 1 2004 33 39
45. P. Thaisetthawatkul, M.L. Collazo-Clavell, M.G. Sarr, J.E. Norell, and P.J. Dyck A controlled study of peripheral neuropathy after bariatric surgery Neurology 63 8 2004 1462 1470
46. B. Morrison, and V. Chaudhry Medication, toxic, and vitamin-related neuropathies Continuum (Minneap Minn) 18 1 2012 139 160
47. A.J. Windebank, and W. Grisold Chemotherapy-induced neuropathy J Peripher Nerv Syst 13 1 2008 27 46
48. J.D. England, and A.K. Asbury Peripheral neuropathy Lancet 363 9427 2004 2151 2161
49. G.J. Braathen, J.C. Sand, A. Lobato, H. Høyer, and M.B. Russell Genetic epidemiology of Charcot-Marie-Tooth in the general population Eur J Neurol 18 1 2011 39 48
50. H. Skre Genetic and clinical aspects of Charcot-Marie-Tooth's disease Clin Genet 6 2 1974 98 118
51. G.J. Braathen Genetic epidemiology of Charcot-Marie-Tooth disease Acta Neurol Scand Suppl 193 2012 iv 22
52. M.A. Saporta Charcot-Marie-Tooth disease and other inherited neuropathies Continuum (Minneap Minn) 20 5, Peripheral Nervous System Disorders 2014 1208 1225
53. M. Haanpää, N. Attal, M. Backonja, and et al. NeuPSIG guidelines on neuropathic pain assessment Pain 152 1 2011 14 27
54. A. Berger, E.M. Dukes, and G. Oster Clinical characteristics and economic costs of patients with painful neuropathic disorders J Pain 5 3 2004 143 149
55. A. Sadosky, C. Schaefer, R. Mann, and et al. Burden of illness associated with painful diabetic peripheral neuropathy among adults seeking treatment in the US: results from a retrospective chart review and cross-sectional survey Diabetes Metab Syndr Obes 6 2013 79 92
56. A.B. O'Connor, and R.H. Dworkin Treatment of neuropathic pain: an overview of recent guidelines Am J Med 122 10, suppl 2009 S22 S32
57. R.H. Dworkin, A.B. O'Connor, J. Audette, and et al. Recommendations for the pharmacological management of neuropathic pain: an overview and literature update Mayo Clin Proc 85 3, suppl 2010 S3 S14
58. N. Attal, G. Cruccu, R. Baron, and et al. EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision Eur J Neurol 17 9 2010 1113-e88
59. N.B. Finnerup, S.H. Sindrup, and T.S. Jensen The evidence for pharmacological treatment of neuropathic pain Pain 150 3 2010 573 581
60. R.H. Dworkin, A.B. O'Connor, M. Backonja, and et al. Pharmacologic management of neuropathic pain: evidence-based recommendations Pain 132 3 2007 237 251
61. V. Bril, J. England, G.M. Franklin, and et al. Evidence-based guideline: treatment of painful diabetic neuropathy: report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation Neurology 76 20 2011 1758 1765
62. L.E. Chaparro, P.J. Wiffen, R.A. Moore, and I. Gilron Combination pharmacotherapy for the treatment of neuropathic pain in adults Cochrane Database Syst Rev 7 2012 CD008943